Clinical trialNCT01208168TerminatedPhase 3Interventional

Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

SponsorPromius Pharma, LLCEnrollment468Onychomycosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objectives of this study are to assess the safety of NAB001 for topical treatment of mild to moderate distal onychomycosis of the toenails over 52 weeks and to compare the efficacy of NAB001 to vehicle alone at the end of the study (Week 56) after treating for 52 weeks.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Joanne Fraser, PhD
Promius Pharma
Study Director
clinicaltrials.gov ↗
Kent Allenby, MD
Promius Pharma
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Dominican Republic

Instituto Dermatologica
Santo Domingo, Dominican Republic
Instituto Dermatologico
Santo Domingo, Dominican Republic

United States

Facility name not stated
Phoenix, Arkansas, United States
T. Joseph Raoof, Md, Inc.
Encino, California, United States
Skin Surgery Medical Group, Inc.
San Diego, California, United States
Longmont Medical Research Network
Longmont, Colorado, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Internaional Dermatology Research, Inc.
Miami, Florida, United States
Medaphase, Inc.
Newnan, Georgia, United States
Clinical Research Atlanta
Stockbridge, Georgia, United States
Northwest Clinical Trials
Boise, Idaho, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
Gerard Furst, Dpm, Pllc
East Setauket, New York, United States
Dermatology Consulting Services
High Point, North Carolina, United States
Wake Research Associates
Raleigh, North Carolina, United States
Mazur Foot and Ankle
Salisbury, North Carolina, United States
Radiant Research
Cincinnati, Ohio, United States
Oregon Dermatology & Research Network
Portland, Oregon, United States
Temple University - School of Podiatric Medicine
Philadelphia, Pennsylvania, United States
Carolina Dermatology of Greenville, Pa
Greenville, South Carolina, United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
Tennessee Clinical Research Center
Nashville, Tennessee, United States
Ashton Podiatry Associates, Pa
Dallas, Texas, United States
Progressive Clinical Research
San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NAB001Vehicle alone

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2010
Primary completion: 31 Jul 2012
Completion: 31 Jul 2012
Last update posted: 11 Jul 2013
Registered enrollment: 468
Registry id: NCT01208168

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.